Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov 24.
doi: 10.1007/s11606-025-10033-7. Online ahead of print.

COVID-19 Vaccination and Kidney Disease : SARS-CoV-2 Vaccine Effect on Risk of Infection and Subsequent Outcomes in Patients with Chronic Kidney Disease

Nicholas Carlson  1   2 , Felix Michalik  3 , Thomas Gerds  4 , Ellen Freese Ballegaard  5   6 , Morten Buus Jørgensen  5 , Karl Emil Nelveg-Kristensen  5 , Pascal Geldsetzer  3 , Mads Hornum  5   6 , Bo Feldt-Rasmussen  5   6 , Christian Torp-Pedersen  7   8
Affiliations

COVID-19 Vaccination and Kidney Disease : SARS-CoV-2 Vaccine Effect on Risk of Infection and Subsequent Outcomes in Patients with Chronic Kidney Disease

Nicholas Carlson et al. J Gen Intern Med. .

Abstract

Background: Benefit of SARS-CoV-2 vaccinations to reduce the risk of infection and subsequent outcomes in patients with impaired kidney function beyond end-stage kidney disease (ESKD) remains uncertain.

Objectives: To evaluate the vaccination effect on rates of SARS-CoV-2 infection and subsequent risk of 30-day mortality outcomes in patients with kidney disease.

Methods: Population-based retrospective cohort on nationwide data from multiple national health care registers between February 2021 and June 2022. All vaccine uptake and efficacy were evaluated in granular eGFR categories with comparison of age- and gender-standardized rates of SARS-CoV-2 infection and subsequent risks of 30-day mortality between unvaccinated, vaccinated, and booster-vaccinated persons.

Results: Based on a population of 982,047 adults with kidney disease, a total of 359,428 SARS-CoV-2 infections (Alpha: n = 7861, Delta: n = 27,868, Omicron: n = 323,699) were identified. Vaccination and booster vaccination were associated with benefits on rates of SARS-CoV-2 infection and subsequent 30-day mortality, with age- and gender-standardized rate ratios for SARS-CoV-2 infection of 0.24 (95% CI 0.21-0.28), 0.33 (95% CI 0.22-0.50), 0.32 (95% CI 0.19-0.54), 0.91 (95% CI 0.32-2.58), and 0.24 (95% CI 0.08-0.73) and age- and gender-standardized 30-day mortality differences of -1.5 (95% CI -1.7, -1.2), -5.8 (95% CI -7.1, -4.5), -12.4 (95% CI -15.3, -9.5), -16.9 (95% CI -21.9, -11.8), and -10.7 (95% CI -16.6, -4.8) for booster vaccinations compared with no vaccination for eGFR ≥ 60 mL/min/1.73 m2, 45-59 mL/min/1.73 m2, 30-44 mL/min/1.73 m2, and < 30 mL/min/1.73 m2 and dialysis, respectively.

Conclusions: Vaccination and booster vaccination against SARS-CoV-2 were associated with benefits on rates of SARS-CoV-2 infections and associated 30-day mortality risk irrespective of kidney function.

Keywords: COVID-19; chronic kidney disease; eGFR; mortality; vaccination.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors declare that they do not have a conflict of interest.

References

REFERENCES

    1. Watson Oj, Barnsley G, Toor J, Hogan Ab, Winskill P, Ghani Ac. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022;22(9). https://doi.org/10.1016/S1473-3099(22)00320-6
    1. ERA-EDTA Council, ERACODA Working Group. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2021;36(1):87–94. https://doi.org/10.1093/ndt/gfaa314
    1. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2021;36(1). https://doi.org/10.1093/ndt/gfaa314
    1. Blake PG, Hladunewich MA, Oliver MJ. COVID-19 Vaccination Imperatives in People on Maintenance Dialysis: An International Perspective. Clin J Am Soc Nephrol. 2021;16(11):1746-1748. https://doi.org/10.2215/CJN.07260521 - DOI - PubMed - PMC
    1. Geetha D, Kronbichler A, Rutter M, et al. Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions. Nat Rev Nephrol. 2022;18(11). https://doi.org/10.1038/s41581-022-00618-4

LinkOut - more resources